Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 12:38 pm Sale |
2020-12-31 | 13G | Vericel Corporation VCEL |
James E. Flynn | 64,946 0.140% |
-2,682,617 (-97.64%) |
Filing History |
| 2021-02-12 12:37 pm Sale |
2020-12-31 | 13G | Vapotherm, Inc. VAPO |
James E. Flynn | 75,565 2.360% |
-63,889 (-45.81%) |
Filing History |
| 2021-02-12 12:37 pm Purchase |
2020-12-31 | 13G | Sientra, Inc. SIEN |
James E. Flynn | 1,655,226 4.985% |
1,232,458 (+291.52%) |
Filing History |
| 2021-02-12 12:36 pm Sale |
2020-12-31 | 13G | Nkarta, Inc. NKTX |
James E. Flynn | 1,419,872 4.360% |
-1,000,000 (-41.32%) |
Filing History |
| 2021-02-12 12:35 pm Sale |
2020-12-31 | 13G | Neuronetics, Inc. STIM |
James E. Flynn | 919,000 11.000% |
-156,000 (-14.51%) |
Filing History |
| 2021-02-12 12:35 pm Purchase |
2020-12-31 | 13G | Intersect ENT, Inc. XENT |
James E. Flynn | 4,438,213 4.985% |
1,641,180 (+58.68%) |
Filing History |
| 2021-02-12 12:34 pm Sale |
2020-12-31 | 13G | Cabaletta Bio, Inc. CABA |
James E. Flynn | 464,252 1.930% |
-1,164,252 (-71.49%) |
Filing History |
| 2021-02-12 12:33 pm Sale |
2020-12-31 | 13G | Axonics, Inc. AXNX |
James E. Flynn | 800,000 2.010% |
-994,594 (-55.42%) |
Filing History |
| 2021-02-12 12:32 pm Sale |
2020-12-31 | 13G | Ardelyx, Inc. ARDX |
James E. Flynn | 10,246,216 2.840% |
-17,770,796 (-63.43%) |
Filing History |
| 2021-02-12 12:31 pm Purchase |
2020-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS |
James E. Flynn | 5,882,353 4.985% |
3,299,062 (+127.71%) |
Filing History |
| 2021-02-12 12:31 pm Sale |
2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
James E. Flynn | 2,721,203 6.160% |
-1,568,088 (-36.56%) |
Filing History |
| 2021-02-12 12:30 pm Purchase |
2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
James E. Flynn | 3,959,741 9.960% |
1,681,588 (+73.81%) |
Filing History |
| 2021-02-12 12:30 pm Sale |
2020-12-31 | 13G | Orchard Therapeutics plc ORTX |
James E. Flynn | 694,942 7.110% |
-191,283 (-21.58%) |
Filing History |
| 2021-02-12 12:29 pm Sale |
2020-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
James E. Flynn | 2,161,000 5.010% |
-208,166 (-8.79%) |
Filing History |
| 2021-02-12 12:28 pm Purchase |
2020-12-31 | 13G | Lumos Pharma, Inc. LUMO |
James E. Flynn | 936,291 11.280% |
936,291 (New Position) |
Filing History |
| 2021-02-12 12:28 pm Unchanged |
2020-12-31 | 13G | IVERIC bio, Inc. ISEE |
James E. Flynn | 5,767,409 6.440% |
0 (Unchanged) |
Filing History |
| 2021-02-12 12:27 pm Sale |
2020-12-31 | 13G | Brookdale Senior Living Inc. BKD |
James E. Flynn | 11,023,465 6.010% |
-6,268,468 (-36.25%) |
Filing History |
| 2021-02-12 12:26 pm Purchase |
2020-12-31 | 13G | BioDelivery Sciences International, Inc. BDSI |
James E. Flynn | 9,530,000 9.430% |
2,984,500 (+45.60%) |
Filing History |
| 2021-02-09 2:21 pm Purchase |
2021-02-09 | 13G | Terns Pharmaceuticals, Inc. TERN |
James E. Flynn | 2,382,033 9.940% |
2,382,033 (New Position) |
Filing History |
| 2021-02-05 12:41 pm Purchase |
2021-01-29 | 13G | Profound Medical Corp. PROF |
James E. Flynn | 1,040,421 5.300% |
1,040,421 (New Position) |
Filing History |